COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06CYI
|
|||
Drug Name |
Nitric Oxide
|
|||
Synonyms |
nitric oxide; nitrogen monoxide; Mononitrogen monoxide; 10102-43-9; nitrosyl; nitrogen monooxide; EDRF; CHEBI:16480; endothelium-derived relaxing factor; monoxyde d'azote; oxoazanyl; oxyde azotique; oxido nitrico; Stickstoffmonoxid; monoxido de nitrogeno; Stickstoff(II)-oxid; Nitric oxide (JAN); INOmax (TN); oxido de nitrogeno(II); Nitrosoradical; [NO]; oxidonitrogen(.); HOA; OHM 11771; Nitric oxide, 98.5%; CHEMBL1200689; DTXSID1020938; CTK0H7679; (.)NO; NO(.); DB00435; (NO)(.); D00074; C00533; Nitric oxide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 2 | [1] | |
Other Indication | Hypertension | Approved | [2] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL
|
|||
Formula |
NO
|
|||
Canonical SMILES |
[N]=O
|
|||
InChI |
1S/NO/c1-2
|
|||
InChIKey |
MWUXSHHQAYIFBG-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 10102-43-9
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:16480
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04290858) Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection. U.S. National Institutes of Health. | |||
2 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 207141. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.